Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database

By afschroeder • January 23, 2026

Campochiaro C, Truchetet ME, Vonk M, De Luca G, Cuomo G, Ananieva LP, Hachulla E, Smith V, Gheorghiu AM, Becvar R, Carreira P, Hunzelmann N, Furst DE, Ortiz-Santamaria V, Del Galdo F, Matucci-Cerinic M, Hoffmann-Vold AM; EUSTAR collaborators. Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database. Arthritis Rheumatol. 2026 Jan 22. doi: 10.1002/art.70043. Epub ahead of print. PMID: 41568546.

Tags: Publications, Rheumatology

Related Posts

Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system ImPrEP CAB Brasil: a hybrid type-2 implementation-effectiveness cohort study

Grinsztejn B, Torres TS, Hoagland B, Coutinho C, Silva MST, Leite IC, Cunha M, Derrico M, Jalil EM, Cardoso SW, Trefiglio R, Farias A, Mourão[...]

Getting to best practice: a practice-oriented checklist for monitoring clinic-level fidelity to hypertension interventions in a large safety-net healthcare system

Korn AR, Gandhi P, R Dopp A, Barron J, Casillas-Salazar R, Durant C, G Morales M, Norwood-Scott E, L Carson S, Casillas A, B Hamilton[...]

Air Pollution Triggers Metabolomic Signature of Mitochondrial Dysfunction in Mice and Humans: Implications for Cardiovascular Disease Development

Lin Y, Qiu X, Gupta R, Ramanathan G, Lu X, Yin F, Fiehn O, Zhang JJ, Kaufman JD, Zhu Y, Rosenfeld M, Araujo JA. Air[...]